| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biosimilars: A Regulatory Review
|
Furlani, Pia
|
|
|
42 |
5 |
p. 477-485
|
artikel
|
| 2 |
Development and Establishment of Good Review Practices for Drug Products in Korea
|
Kim, Young-Ok
|
|
|
42 |
5 |
p. 487-491
|
artikel
|
| 3 |
Good Practices for Handling Adverse Events Detected through Patient Registries
|
Dreyer, Nancy A.
|
|
|
42 |
5 |
p. 421-428
|
artikel
|
| 4 |
Implementation of a Phase 1 Adaptive Clinical Trial in a Treatment of Type 2 Diabetes
|
Tibaldi, Fabián S.
|
|
|
42 |
5 |
p. 455-465
|
artikel
|
| 5 |
On the Amendments of China’s Provisions for Drug Registration
|
Zhao, Naiqing
|
|
|
42 |
5 |
p. 467-475
|
artikel
|
| 6 |
Pharmacogenetics: From Bench Science to the Bedside
|
Shih, Ted
|
|
|
42 |
5 |
p. 503-513
|
artikel
|
| 7 |
Report of Task Force II: Best Practices in the Use of Medical Imaging Techniques in Clinical Trials
|
Ford, Robert
|
|
|
42 |
5 |
p. 515-523
|
artikel
|
| 8 |
Sample Size Algorithms in Clinical Trials
|
Wu, Chien-Hua
|
|
|
42 |
5 |
p. 429-439
|
artikel
|
| 9 |
Some Guidelines for Interim Data Review of Clinical Trial Data
|
King, Dennis W.
|
|
|
42 |
5 |
p. 449-453
|
artikel
|
| 10 |
Statistical Thinking for Non-Statisticians in Drug Regulation
|
DeWyngaert, Mark A.
|
|
|
42 |
5 |
p. 525-526
|
artikel
|
| 11 |
The Effects of Physicians’ Financial Incentives on the Effectiveness of Taiwan’s Outpatient Drug Copayment Policy
|
Chu, Hsuan-Lien
|
|
|
42 |
5 |
p. 493-502
|
artikel
|
| 12 |
Urn-Based Response Adaptive Procedures and Optimality
|
Bhattacharya, Rahul
|
|
|
42 |
5 |
p. 441-448
|
artikel
|
| 13 |
VigiBase, the WHO Global ICSR Database System: Basic Facts
|
Lindquist, Marie
|
|
|
42 |
5 |
p. 409-419
|
artikel
|
Tijdschrift beschrijving